| Measure Code | Measure Title | Performance Rate | Patient Count | Star Value | Five Star Benchmark | Collection Type |
|---|---|---|---|---|---|---|
| IA_EC_PM_16 | Implementation of medication management practice improvements | |||||
| IA_EC_PSPA_1 | Participation in an AHRQ-listed patient safety organization. | |||||
| IA_EC_PSPA_16 | Use of decision support and standardized treatment protocols | |||||
| IA_EC_PSPA_21 | Implementation of fall screening and assessment programs | |||||
| MIPS_EC_005_overall | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) | 90 | 31 | EHR | ||
| MIPS_EC_007_overall | Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) | 90 | 142 | EHR | ||
| MIPS_EC_001_overall | Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) | 74 | 163 | EHR | ||
| MIPS_EC_008_overall | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) | 90 | 31 | EHR | ||
| MIPS_EC_119_overall | Diabetes: Medical Attention for Nephropathy | 89 | 163 | 4 | 100 | EHR |
| MIPS_EC_226_overall | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 23 | 91 | 1 | 100 | EHR |
| MIPS_EC_226_screenedForUse | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 95 | 1332 | EHR | ||
| MIPS_EC_226_tobacco | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 90 | 1332 | EHR | ||
| MIPS_EC_236_overall | Controlling High Blood Pressure | 69 | 1515 | EHR | ||
| MIPS_EC_318_overall | Falls: Screening for Future Fall Risk | 87 | 1499 | 4 | 100 | EHR |
| MIPS_EC_317_overall | Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented | 23 | 2204 | 2 | 64 | EHR |